Lin R, Zheng S, Su H, Wang G, Li X, Lu C
Phenomics. 2025; 4(6):570-583.
PMID: 40061822
PMC: 11889321.
DOI: 10.1007/s43657-024-00183-9.
Ban M, Jiao J, Zhou J, Cui L, Wang H, Chen Z
J Ovarian Res. 2025; 18(1):40.
PMID: 40011967
PMC: 11863671.
DOI: 10.1186/s13048-025-01629-y.
Abu-Zaid A, Alzayed M, Albahrani S, Almaqhawi A, Al Shaikh M, Baradwan S
Medicina (Kaunas). 2025; 61(2).
PMID: 40005397
PMC: 11857371.
DOI: 10.3390/medicina61020280.
Chan R, Huang C, Ng N, Tam H, Tam C, Cheng F
Endocrinol Diabetes Metab. 2025; 8(2):e70030.
PMID: 39963020
PMC: 11833164.
DOI: 10.1002/edm2.70030.
Longo M, Liuzzi F, De Carlini S, La Marca A
Reprod Biol Endocrinol. 2025; 23(Suppl 1):22.
PMID: 39930391
PMC: 11808943.
DOI: 10.1186/s12958-025-01353-8.
Ovarian function measures in normogonadotropic anovulation and subclinical thyroid dysfunction: a prospective cohort study.
Gawron I, Baran R, Jach R
Endocrine. 2025; .
PMID: 39743639
DOI: 10.1007/s12020-024-04151-1.
Evaluation of Biochemical Serum Markers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Obese Women in Kazakhstan: Is Anti-Müllerian Hormone a Potential Marker?.
Madikyzy M, Durmanova A, Trofimov A, Akbay B, Tokay T
Biomedicines. 2024; 12(10).
PMID: 39457645
PMC: 11504444.
DOI: 10.3390/biomedicines12102333.
Disclosing α-lactalbumin impact on the intestinal and vaginal microbiota of women suffering from polycystic ovary syndrome.
Alessandri G, Mancabelli L, Fontana F, Lepore E, Forte G, Burratti M
Microb Biotechnol. 2024; 17(10):e14540.
PMID: 39364592
PMC: 11450379.
DOI: 10.1111/1751-7915.14540.
Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome.
Mansour A, Noori M, Hakemi M, Haghgooyan Z, Mohajeri-Tehrani M, Mirahmad M
BMC Endocr Disord. 2024; 24(1):201.
PMID: 39333998
PMC: 11438141.
DOI: 10.1186/s12902-024-01733-y.
Effects of interleukin-1 receptor antagonism in women with polycystic ovary syndrome-the FertIL trial.
Walchli-Popovic M, Monnerat S, Taylor A, Gilligan L, Schiffer L, Arlt W
Front Endocrinol (Lausanne). 2024; 15:1435698.
PMID: 39324125
PMC: 11423739.
DOI: 10.3389/fendo.2024.1435698.
Gonadotropin Activity during Early Folliculogenesis and Implications for Polycystic Ovarian Syndrome and Premature Ovarian Insufficiency: A Narrative Review.
Longobardi S, Klinger F, Zheng W, Campitiello M, DHooghe T, La Marca A
Int J Mol Sci. 2024; 25(14).
PMID: 39062762
PMC: 11277126.
DOI: 10.3390/ijms25147520.
The association of CYP11A1 gene polymorphisms with the polycystic ovary syndrome patients.
Alyousif S, Ozbakir B, Ozay A, Tulay P
Rev Assoc Med Bras (1992). 2024; 70(7):e20231293.
PMID: 39045925
PMC: 11262315.
DOI: 10.1590/1806-9282.20231293.
Nutritional and exercise interventions to improve conception in women suffering from obesity and distinct nosological entities.
Gitsi E, Livadas S, Argyrakopoulou G
Front Endocrinol (Lausanne). 2024; 15:1426542.
PMID: 39006367
PMC: 11239444.
DOI: 10.3389/fendo.2024.1426542.
Therapeutic Effects of Fruit Extract on Polycystic Ovary Syndrome in a Rat Model: Emerging Role of Inflammatory Responses and Oxidative Stress.
Dadkhah M, Gholizadeh N, Nasimi Doost Azgomi R, Hosseinzadeh S, Hamedeyazdan S, Haghighat K
Iran J Pharm Res. 2024; 23(1):e143290.
PMID: 39005731
PMC: 11246645.
DOI: 10.5812/ijpr-143290.
Diacerein mitigates endocrine and cardio-metabolic disruptions in experimental PCOS mice model by modulating AdipoR1/ PON 1.
Shah M, Shrivastava V, Muzamil S, Olaniyi K
BMC Endocr Disord. 2024; 24(1):109.
PMID: 38982395
PMC: 11234745.
DOI: 10.1186/s12902-024-01639-9.
ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations.
Asadi M, Klashami Z, Panahi N, Oheb Y, Khorasani S, Amoli M
J Diabetes Metab Disord. 2024; 23(1):681-688.
PMID: 38932810
PMC: 11196500.
DOI: 10.1007/s40200-023-01335-w.
Dual Oxidase 1, 2 Gene Expression in Women With Polycystic Ovary Syndrome (PCOS).
Hesampour A, Jafarabadi M, Rajabi S, Rezayof E, Nezamabadi A
J Family Reprod Health. 2024; 17(4):205-215.
PMID: 38807627
PMC: 11128735.
DOI: 10.18502/jfrh.v17i4.14592.
Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review.
Choudhari R, Tayade S, Tiwari A, Satone P
Cureus. 2024; 16(4):e58733.
PMID: 38779261
PMC: 11110474.
DOI: 10.7759/cureus.58733.
Serum Expression of miR-23a-3p and miR-424-5p Indicate Specific Polycystic Ovary Syndrome Phenotypes: A Pilot Study.
Trummer O, Hoeller J, Reintar S, Tandl V, Foessl I, Borzan V
Int J Mol Sci. 2024; 25(6).
PMID: 38542179
PMC: 10970470.
DOI: 10.3390/ijms25063205.
Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid- stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients.
Mahmud A, Anu U, Foysal K, Hasan M, Sazib S, Ragib A
Narra J. 2024; 2(1):e56.
PMID: 38450391
PMC: 10914094.
DOI: 10.52225/narra.v2i1.56.